STUDY PROTOCOL FOR A COMPASSIONATE AQUACULTURE INVESTIGATIONAL NEW ANIMAL DRUG (INAD) EXEMPTION FOR AQUI-S®20E (eugenol) (INAD #11-741)

Document - application/pdf
STUDY PROTOCOL FOR A COMPASSIONATE AQUACULTURE INVESTIGATIONAL NEW ANIMAL DRUG (INAD) EXEMPTION FOR AQUI-S®20E (eugenol) (INAD #11-741)

Aqui-S®20E is a liquid containing 10% eugenol that is applied as an immersion bath treatment. Aqui-S®20E is only available for purchase through Merck Animal Health. The primary goal of field studies conducted under INAD #11-741 is to evaluate the efficacy of Aqui-S®20E for use as an anesthetic/sedative in all freshwater-reared finfish, freshwater prawn, all saltwater-reared finfish, and sharks.

Attachments
AttachmentSize
AQUIS20E-study-protocol-2023.pdf580.28 KB580.28 KB
Author(s)
Publication date
Type of document
Protocol
Program
Juvenile Northern Pike in aquarium at Gavins Point National Fish Hatchery, South Dakota
The Fish and Aquatic Conservation program leads aquatic conservation efforts for the U.S. Fish and Wildlife Service. We are committed to tackling the nation’s highest priority aquatic conservation and recreational challenges to conserve, restore, and enhance fisheries for future generations.
A fish with a reddish tone body with black spots on upper part of body, this side view of a Chinook salmon shows the salmon swimming right above a gravel riverbed.
Healthy fisheries are core to the conservation work of the U.S. Fish and Wildlife Service. We are working with partners to protect and enhance the health of fish and other aquatic animals in aquaculture and in the wild.